Leukemia Research
Volume 27, Issue 6 , Pages 517-527 , June 2003

Flavonoid effects on normal and leukemic cells

  • Jane L Liesveld

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • Corresponding Author InformationCorresponding author. Present address: Bux Fuy Strong Memorial Hospital, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA. Tel.: +1-585-275-4099; fax: +1-585-273-1051.
    • ,
  • Camille N Abboud

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Chaohui Lu

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Curtiss McNair II

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Aarti Menon

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Alan Smith

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Karen Rosell

      Affiliations

    • Department of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
    • ,
  • Aaron P Rapoport

      Affiliations

    • Greenebaum Cancer Center, The University of Maryland, Baltimore, MD, USA

Received 20 June 2002 ,Accepted 4 October 2002.

References 

  1. Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E, et al. Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience. Cancer. 1997;80:2205
  2. Reykdal S, Abboud CN, Liesveld JL. Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture. Exp. Hematol. 1999;27:441
  3. Larocca LM, Teofili L, Leone G, Sica S, Pierelli L, Menichella G, et al. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. Br. J. Haematol. 1991;79:562
  4. Larocca LM, Ranelleti FO, Maggiano N, Rutella S, LaBarbera EO, Rumi C, et al. Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70. Int. J. Cancer. 1997;73:75
  5. Arguello F, Alexander M, Sterry JA, Tudor G, Smith EM, Kalavar NT, et al. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood. 1998;92:2482
  6. Parker BW, Kaur G, Nieves-Neira W, Taimi M, Kohlhagen G, Shimizu T, et al. Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood. 1998;91:458
  7. Senderowicz AM. Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Leukemia. 2001;15:1
  8. Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, et al. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase 3 without evidence of bcl-2 modulation or dependence on functional p53. Blood. 1998;92:3804
  9. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge D. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood. 1991;78:666
  10. Uddin S, Choudhry MA. Quercetin: a bioflavonoid, inhibits the DNA synthesis of human leukemia cells. Biochem. Mol. Biol. Int. 1995;36:545
  11. Ito T, Warnken SP, May WS. Protein synthesis inhibition by flavonoids: roles of eukaryotic initiation factor 2 alpha kinases. Biochem. Biophys. Res. Commun. 1999;265:589
  12. Csokay B, Prajda N, Weber G, Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 1997;60:2157
  13. Larocca LM, Teofili L, Sica S, Paintelli M, Maggiano N, Leone G, et al. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood. 1995;85:3654
  14. Senderowicz AM, Sausville EA. Preclinical and clinical development of cyclin-dependent kinase modulators. J. Natl. Cancer Inst. 2000;92:376
  15. Kitada S, Zapata JM, Andreeff M, Reed JC. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. Blood. 2000;96:393
  16. Mehmet H. Caspases find a new place to hide. Nature. 2000;403:29
  17. Turnbull KJ, Brown BL, Dobson PR. Caspase 3-like activity is necessary but not sufficient for daunorubicin-induced apoptosis in Jurkat human lymphoblastic leukemia cells. Leukemia. 1999;18:1056
  18. Motwani M, Delhery TM, Schwartz GK. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res. 1999;5:1875
  19. Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M, et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood. 1998;92:3090
  20. Okuma E, Saeki K, Shimura M, Ishizaka Y, Yasugi E, You A. Induction of apoptosis in human hematopoietic U937 cells by granulocyte–macrophage colony stimulating factor: possible existence of caspase 3-like pathway. Leukemia. 2000;14:612
  21. Lahusen J, Loaiza-Perez A, Sausville EA, Senderowicz AM. Flavopiridol-induced apoptosis is associated with p38 and MEK activation and is prevented by caspase and MAPK inhibitors. Proc. AACR. 2000;41:313; (abstract)
  22. Rapoport AP, Simons-Evelyn M, Chen T, Sidell R, Luhowskyj S, Rosell K, et al. Flavopiridol induces apoptosis and caspase 3 activation of a newly characterized Burkitt’s lymphoma cell line containing mutant p53 genes. Blood Cells, Mol. Dis. 2001;27:610
  23. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos T. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997;27:1
  24. Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 2000;25:639
  25. List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL. Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors. Leukemia. 1998;12:1596
  26. Dimitroulakos J, Nohynek D, Backway KL, Hedley DW, Yeger H, Freedman MH, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach. Blood. 1999;93:1308
  27. Ross DD. Novel mechanisms of drug resistance in leukemia. Leukemia. 2000;24:467
  28. Kolb J-P. Mechanisms involved in the pro-and antiapoptotic role of NO in human leukemia. Leukemia. 2000;14:1685
  29. Elsayed YA, Sausville EA. Selected novel anticancer treatments targeting cell signaling proteins. The Oncol. 2001;6:517

☆ Supported by ACS grant DHP-173. JLL is a Clinical Scholar of the Leukemia and Lymphoma Society of America.

PII: S0145-2126(02)00265-5

doi: 10.1016/S0145-2126(02)00265-5

Leukemia Research
Volume 27, Issue 6 , Pages 517-527 , June 2003

Article Tools

* Image Usage & Resolution